NCT02041650View on ClinicalTrials.gov

Paradigm Shift in the Treatment of Patients With ACS

PHASE4CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2017

Conditions
Acute Coronary Syndrome
Interventions
DRUG

Ticagrelor

Trial Locations (1)

150086

The 2nd Affiliated Hospital of Harbin Medical University, Harbin

All Listed Sponsors
collaborator

Massachusetts General Hospital

OTHER

lead

Yu Bo

OTHER

NCT02041650 - Paradigm Shift in the Treatment of Patients With ACS | Biotech Hunter | Biotech Hunter